Led jointly by the University of Florida and the University of North Carolina at Chapel Hill, HCV-TARGET is an international research consortium created to inform the ongoing transformation of hepatitis C treatment and research.

 

Steering Committee

  • Michael Fried, M.D. (Co-PI, Data Coordinating Center)
  • David Nelson, M.D. (Co-PI, Clinical Coordinating Center)
  • Adrian Di Bisceglie, M.D.
  • Raj Reddy, M.D.
  • Mark Sulkowski, M.D.
  • Norah Terrault, M.D.
  • Joseph Lim, M.D.
  • Ira Jacobson, M.D.
  • Michael Manns, M.D.
  • Robert S. Brown, M.D.
  • Joy Peter, R.N.

Publication Committee

  • Raj Reddy, M.D. (Chair)
  • Norah Terrault, M.D.
  • Michael Fried, M.D.
  • Jordan Feld, M.D.
  • Mitchell Shiffman, M.D.

HCV Community Advocates Committee

  • Lorren Sandt- HCV Caring Ambassadors
  • Jules Levin- NATAP
  • Michael Ninburg- Hepatitis Education Project

HCV-TARGET Sites

  • 38 academic sites
  • 15 community sites

Sponsors

  • Genentech, Kadmon, Merck, Vertex, Janssen, AbbVie, Gilead Sciences, Bristol Myers Squibb, Glaxo Smith Kline